{"id":"segesterone-acetate-and-ethinyl-estradiol","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Breast tenderness"},{"rate":null,"effect":"Irregular bleeding/spotting"},{"rate":null,"effect":"Mood changes"}]},"_chembl":null,"_dailymed":{"setId":"eb18194f-2021-41fa-8bdf-31e0c0eb646b","title":"ANNOVERA (SEGESTERONE ACETATE AND ETHINYL ESTRADIOL) RING [MAYNE PHARMA]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Segesterone acetate is a selective progesterone receptor agonist that works synergistically with ethinyl estradiol (a synthetic estrogen) to inhibit the luteinizing hormone (LH) surge required for ovulation. The combination also thickens cervical mucus to impede sperm penetration and alters the endometrium to prevent implantation, providing multiple layers of contraceptive protection.","oneSentence":"A progestin-estrogen combination that suppresses ovulation and alters cervical mucus and endometrial environment to prevent pregnancy.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T04:25:04.862Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Contraception in women of reproductive potential"}]},"trialDetails":[{"nctId":"NCT07398924","phase":"NA","title":"Vaginal Estradiol and Oral Guaifenesin in Clomiphene Ovulation Induction","status":"COMPLETED","sponsor":"Yuzuncu Yil University","startDate":"2022-01-06","conditions":"Female Infertility, Anovulatory Infertility, Unexplained Infertility","enrollment":90},{"nctId":"NCT04272008","phase":"PHASE1","title":"The Effects of Annovera™ and Tampon Co-Usage on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol","status":"COMPLETED","sponsor":"TherapeuticsMD","startDate":"2020-03-06","conditions":"Contraception","enrollment":21},{"nctId":"NCT04290390","phase":"PHASE1","title":"Annovera™ Drug-Drug Interaction Study","status":"COMPLETED","sponsor":"TherapeuticsMD","startDate":"2020-02-12","conditions":"Women, Contraception","enrollment":67},{"nctId":"NCT02516202","phase":"PHASE3","title":"The Vaginal Health Trial","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2016-04","conditions":"Atrophy of Vagina, Menopause, Dyspareunia (Female)","enrollment":302},{"nctId":"NCT00263341","phase":"PHASE3","title":"Safety and Efficacy of a Contraceptive Vaginal Ring Delivering Nestorone® and Ethinyl Estradiol","status":"COMPLETED","sponsor":"Population Council","startDate":"2005-12","conditions":"Contraception","enrollment":1135}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":12,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Annovera"],"phase":"marketed","status":"active","brandName":"Segesterone Acetate and Ethinyl Estradiol","genericName":"Segesterone Acetate and Ethinyl Estradiol","companyName":"TherapeuticsMD","companyId":"therapeuticsmd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A progestin-estrogen combination that suppresses ovulation and alters cervical mucus and endometrial environment to prevent pregnancy. Used for Contraception in women of reproductive potential.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}